Isorad

Isorad Overview

Isorad Ltd. was established in order to commercialize technologies which have been developed in the Soreq Nuclear Research Center (NRC). Over the years, Isorad has been involved in nuclear medicine by manufacturing radiopharmaceutical medicines and radiodiagnostic materials, aimed at both diagnostic and therapeutic purposes. Our major products are radionuclides such as 99Mo/99mTc (Molybdenum or Technetium isotopes as Sodium compounds) used in cancer diagnosis. Other products include: - Gallium citrate (Ga67) injection - for localization of malignant growths - Iodium 123 for for diagnosis of medullary tumors, Diagnosis of neural crest tumor - OctreoScan for diagnosis and management of receptorbearing gastro-entero-pancreatic neuroendocrine tumors Isorad supplies any type of the SPECT range of cancer diagnostic products, PET diagnostic products, MRI contrast agents, and several Nuclear Therapeutic materials such as LU-177. In addition, our sterile aseptic manufacturing facility, built to meet the most advanced cGMP standards, produces various labeling agents by Liquid Fill and Lyophilization processes. The facility is capable of providing the required infrastructure for pharmaceutical companies seeking to outsource part of their production activities.

Latest News

No news articles.

Funding

Team Members

2

Employees: 11-50

Web & Social Links

Locations

Yavne, Israel

Photos & Videos

1 item(s)

Isorad Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info